Your browser doesn't support javascript.
loading
Complement in Tumourigenesis and the Response to Cancer Therapy.
O'Brien, Rebecca M; Cannon, Aoife; Reynolds, John V; Lysaght, Joanne; Lynam-Lennon, Niamh.
Afiliação
  • O'Brien RM; Department of Surgery, Trinity St. James's Cancer Institute, Trinity Translational Medicine Institute, Trinity College Dublin and St. James's Hospital, Dublin 8, Ireland.
  • Cannon A; Cancer Immunology and Immunotherapy Group, Trinity St. James's Cancer Institute, Trinity Translational Medicine Institute, Trinity College Dublin and St. James's Hospital, Dublin 8, Ireland.
  • Reynolds JV; Department of Surgery, Trinity St. James's Cancer Institute, Trinity Translational Medicine Institute, Trinity College Dublin and St. James's Hospital, Dublin 8, Ireland.
  • Lysaght J; Department of Surgery, Trinity St. James's Cancer Institute, Trinity Translational Medicine Institute, Trinity College Dublin and St. James's Hospital, Dublin 8, Ireland.
  • Lynam-Lennon N; Department of Surgery, Trinity St. James's Cancer Institute, Trinity Translational Medicine Institute, Trinity College Dublin and St. James's Hospital, Dublin 8, Ireland.
Cancers (Basel) ; 13(6)2021 Mar 10.
Article em En | MEDLINE | ID: mdl-33802004
In recent years, our knowledge of the complement system beyond innate immunity has progressed significantly. A modern understanding is that the complement system has a multifaceted role in malignancy, impacting carcinogenesis, the acquisition of a metastatic phenotype and response to therapies. The ability of local immune cells to produce and respond to complement components has provided valuable insights into their regulation, and the subsequent remodeling of the tumour microenvironment. These novel discoveries have advanced our understanding of the immunosuppressive mechanisms supporting tumour growth and uncovered potential therapeutic targets. This review discusses the current understanding of complement in cancer, outlining both direct and immune cell-mediated roles. The role of complement in response to therapies such as chemotherapy, radiation and immunotherapy is also presented. While complement activities are largely context and cancer type-dependent, it is evident that promising therapeutic avenues have been identified, in particular in combination therapies.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article